Research
Education
Solutions
Sign In
EN
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
TR - Turkish
JA - Japanese
Departments of Microbiology & Immunology
Thulasi Warrier has not added Biography.
If you are Thulasi Warrier and would like to personalize this page please email our Author Liaison for assistance.
Old fold in a new X-ray diffraction dataset? Low-resolution molecular replacement using representative structural templates can provide phase information.
Proteins Sep, 2006 | Pubmed ID: 16786600
Small-molecule scaffolds for CYP51 inhibitors identified by high-throughput screening and defined by X-ray crystallography.
Antimicrobial agents and chemotherapy Nov, 2007 | Pubmed ID: 17846131
X-ray structure of 4,4'-dihydroxybenzophenone mimicking sterol substrate in the active site of sterol 14alpha-demethylase (CYP51).
The Journal of biological chemistry May, 2008 | Pubmed ID: 18367444
Identification of small-molecule scaffolds for p450 inhibitors.
Current protocols in microbiology Feb, 2010 | Pubmed ID: 20131225
Antigen 85C inhibition restricts Mycobacterium tuberculosis growth through disruption of cord factor biosynthesis.
Antimicrobial agents and chemotherapy Apr, 2012 | Pubmed ID: 22290959
Nonsteroidal anti-inflammatory drug sensitizes Mycobacterium tuberculosis to endogenous and exogenous antimicrobials.
Proceedings of the National Academy of Sciences of the United States of America Oct, 2012 | Pubmed ID: 23012453
N,C-Capped dipeptides with selectivity for mycobacterial proteasome over human proteasomes: role of S3 and S1 binding pockets.
Journal of the American Chemical Society Jul, 2013 | Pubmed ID: 23782398
Benzimidazole-based compounds kill Mycobacterium tuberculosis.
European journal of medicinal chemistry Mar, 2014 | Pubmed ID: 24556148
Synthetic calanolides with bactericidal activity against replicating and nonreplicating Mycobacterium tuberculosis.
Journal of medicinal chemistry May, 2014 | Pubmed ID: 24694175
A multi-stress model for high throughput screening against non-replicating Mycobacterium tuberculosis.
Methods in molecular biology (Clifton, N.J.) , 2015 | Pubmed ID: 25779324
Rapid, Semiquantitative Assay To Discriminate among Compounds with Activity against Replicating or Nonreplicating Mycobacterium tuberculosis.
Antimicrobial agents and chemotherapy Oct, 2015 | Pubmed ID: 26239979
Novel Cephalosporins Selectively Active on Nonreplicating Mycobacterium tuberculosis.
Journal of medicinal chemistry Jul, 2016 | Pubmed ID: 27144688
N-methylation of a bactericidal compound as a resistance mechanism in Mycobacterium tuberculosis.
Proceedings of the National Academy of Sciences of the United States of America Aug, 2016 | Pubmed ID: 27432954
Identification of Novel Anti-mycobacterial Compounds by Screening a Pharmaceutical Small-Molecule Library against Nonreplicating Mycobacterium tuberculosis.
ACS infectious diseases Dec, 2015 | Pubmed ID: 27623055
Weill Cornell Medical College
Ben Gold1,
Julia Roberts*,1,
Yan Ling*,1,
Landys Lopez Quezada1,
Jou Glasheen1,
Elaine Ballinger1,
Selin Somersan-Karakaya2,
Thulasi Warrier1,
Carl Nathan1
1Departments of Microbiology & Immunology, Weill Cornell Medical College,
2Medicine, Weill Cornell Medical College
Privacy
Terms of Use
Policies
Contact Us
Recommend to library
JoVE NEWSLETTERS
JoVE Journal
Methods Collections
JoVE Encyclopedia of Experiments
Archive
JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
Faculty Resource Center
Authors
Librarians
Access
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved